Key result
Daytime ventilatory oscillations in heart failure result from chemoreflex resonance, where increased loop gain strongly correlates with the strength of spontaneous oscillations (r = 0.88, P < 0.001).
Why the study?
Does chemoreflex resonance explain daytime ventilatory oscillations in patients with heart failure?
Observational (n=50)
Does chemoreflex resonance explain daytime ventilatory oscillations in patients with heart failure?
Answers are grounded in this paper and cite their sources.
Daytime ventilatory oscillations in heart failure result from chemoreflex resonance, providing a physiological marker for chemoreflex hypersensitivity and reduced stability.
Rationale In patients with chronic heart failure, daytime oscillatory breathing at rest is associated with a high risk of mortality. Experimental evidence, including exaggerated ventilatory responses to CO2 and prolonged circulation time, implicates the ventilatory control system and suggests feedback instability (loop gain > 1) is responsible. However, daytime oscillatory patterns often appear remarkably irregular versus classic instability (Cheyne-Stokes respiration), suggesting our mechanistic understanding is limited. Objectives We propose that daytime ventilatory oscillations generally result from a chemoreflex resonance, in which spontaneous biological variations in ventilatory drive repeatedly induce temporary and irregular ringing effects. Importantly, the ease with which spontaneous biological variations induce irregular oscillations (resonance “strength”) rises profoundly as loop gain rises toward 1. We tested this hypothesis through a comparison of mathematical predictions against actual measurements in patients with heart failure and healthy control subjects. Methods In 25 patients with chronic heart failure and 25 control subjects, we examined spontaneous oscillations in ventilation and separately quantified loop gain using dynamic inspired CO2 stimulation. Measurements and Main Results Resonance was detected in 24 of 25 patients with heart failure and 18 of 25 control subjects. With increased loop gain—consequent to increased chemosensitivity and delay—the strength of spontaneous oscillations increased precipitously as predicted (r = 0.88), yielding larger (r = 0.78) and more regular (interpeak interval SD, r = −0.68) oscillations (P < 0.001 for all, both groups combined). Conclusions Our study elucidates the mechanism underlying daytime ventilatory oscillations in heart failure and provides a means to measure and interpret these oscillations to reveal the underlying chemoreflex hypersensitivity and reduced stability that foretells mortality in this population.
No takes yet. Share an insight, caveat, or question.
Sands et al. (2016) conducted an observational in Chronic heart failure (n=50). Dynamic inspired CO2 stimulation (to measure loop gain) vs. Healthy controls was evaluated on Correlation between oscillatory strength and loop gain (r = 0.88, p=<0.001). Daytime ventilatory oscillations in heart failure result from chemoreflex resonance, where increased loop gain strongly correlates with the strength of spontaneous oscillations (r = 0.88, P < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: